A phase 1 study evaluating the pharmacokinetics, safety and tolerability of repeat dosing with a human IL-13 antibody (CAT-354) in subjects with asthma

Overview of attention for article published in BMC Pulmonary Medicine, January 2010

Altmetric Badge

About this Attention Score

So far, Dimensions has found 75 publications that cite this research output.

Article in Meditsinskiy sovet = Medical Council (October 2022)

Article in Cochrane Database of Systematic Reviews (July 2022)

Article in Allergies (June 2022)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.